Q27.3
Arteriovenous malformation (peripheral)
Clinical Classification Guidelines
Inclusion Terms
- Arteriovenous aneurysm
Excludes Type 1
- acquired arteriovenous aneurysm (I77.0)
Excludes Type 2
- arteriovenous malformation of cerebral vessels (Q28.2)
- arteriovenous malformation of precerebral vessels (Q28.0)
Medical Intelligence & Overview
Peripheral arteriovenous malformation (AVM) is a rare vascular condition involving an abnormal connection between arteries and veins located outside of the central nervous system, generally in the limbs or other peripheral areas. This congenital anomaly disrupts normal blood flow, potentially causing swelling, pain, or other complications. Recognized under ICD-10 code Q27.3, these malformations can vary widely in size and severity, affecting quality of life and requiring careful medical management.
Causes & Symptoms
Clinical Causes: Congenital developmental abnormality present at birth Genetic factors that may predispose to vascular malformations Potential association with hereditary syndromes such as hereditary hemorrhagic telangiectasia (HHT)
Key Symptoms: Unusual swelling or a lump in the affected area Pulsating sensation or bruit heard over the malformation Discoloration of skin over the AVM Pain or tenderness in the affected region Ulceration or bleeding if the abnormal vessels rupture Signs of high-output cardiac failure in extensive cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of peripheral arteriovenous malformations involves a combination of clinical evaluation and imaging studies. Techniques include:
Treatment Protocols: Management strategies depend on the size, location, symptoms, and potential complications of the AVM. Options include:
Clinical Advice & FAQs
Billing Guidance
Is Q27.3 a billable ICD-10 code?
Yes, Q27.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q27.3?
Clinical documentation must specify the nature of Arteriovenous malformation (peripheral) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
